loading
전일 마감가:
$2.50
열려 있는:
$2.4322
하루 거래량:
1,825
Relative Volume:
0.08
시가총액:
$6.22M
수익:
$453.80K
순이익/손실:
$-1.03M
주가수익비율:
-3.5217
EPS:
-0.7184
순현금흐름:
-
1주 성능:
+2.43%
1개월 성능:
-12.15%
6개월 성능:
-22.01%
1년 성능:
-87.31%
1일 변동 폭
Value
$2.4322
$2.53
1주일 범위
Value
$2.32
$2.69
52주 변동 폭
Value
$2.0101
$41.12

X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Company Profile

Name
명칭
X T L Biopharmaceuticals Ltd Adr
Name
전화
-
Name
주소
-
Name
직원
2
Name
트위터
@xtlbio
Name
다음 수익 날짜
2026-04-29
Name
최신 SEC 제출 서류
Name
XTLB's Discussions on Twitter

Compare XTLB vs VRTX, REGN, ARGX, MRNA, RVMD

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
XTLB icon
XTLB
X T L Biopharmaceuticals Ltd Adr
2.53 6.79M 453.80K -1.03M 0 -0.7184
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
546.12 136.93B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
827.72 85.11B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
1,033.15 64.95B 4.16B 1.29B 734.26M 19.58
MRNA icon
MRNA
Moderna Inc
145.55 53.23B 2.23B -3.19B -1.60B -8.1462
RVMD icon
RVMD
Revolution Medicines Inc
210.02 45.38B 742.00K -1.37B -1.07B -7.0731

X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2015-05-08 개시 H.C. Wainwright Buy

X T L Biopharmaceuticals Ltd Adr 주식(XTLB)의 최신 뉴스

pulisher
Aug 05, 2026

XTL Biopharmaceuticals Faces Derivative Action Bid Over Failed Social Proxy Acquisition - TipRanks

Aug 05, 2026
pulisher
Jul 25, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Revenue Breakdown – FWB:HHB0 - TradingView

Jul 25, 2026
pulisher
Jul 22, 2026

XTL Biopharmaceuticals Regains Nasdaq Compliance and Enters One-Year Monitoring Period - The Globe and Mail

Jul 22, 2026
pulisher
Jul 21, 2026

XTLB Stock Price, Quote & Chart - ChartMill

Jul 21, 2026
pulisher
Jul 12, 2026

Enterprise value to EBITDA forward of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView

Jul 12, 2026
pulisher
Jun 30, 2026

XTL Biopharmaceuticals Completes Psyga Bio Acquisition, Refocuses on Psychedelic Medicine - TipRanks

Jun 30, 2026
pulisher
Jun 29, 2026

XTL Biopharmaceuticals Shareholders Approve Psyga Bio Acquisition and Major Capital Increase - TipRanks

Jun 29, 2026
pulisher
Jun 29, 2026

Wondering what's happening in today's after-hours session? - ChartMill

Jun 29, 2026
pulisher
Jun 29, 2026

XTL Biopharmaceuticals Adjourns Extraordinary Shareholder Meeting to June 29, 2026 - TipRanks

Jun 29, 2026
pulisher
May 29, 2026

XTL Biopharmaceuticals (XTLB) Stock Price, News & Analysis $XTLB - MarketBeat

May 29, 2026
pulisher
May 26, 2026

XTLB - Finviz

May 26, 2026
pulisher
May 22, 2026

XTL Biopharmaceuticals Faces Added Nasdaq Delisting Risk Over Late 2025 Annual Report - TipRanks

May 22, 2026
pulisher
May 22, 2026

XTL Biopharmaceuticals faces additional Nasdaq delisting risk - Investing.com

May 22, 2026
pulisher
May 20, 2026

Eastern International Ltd. expands board, appoints two new directors - Investing.com

May 20, 2026
pulisher
May 16, 2026

XTL Biopharmaceuticals Calls June 22, 2026 Meeting to Approve Psyga Bio Acquisition and Capital Raise - The Globe and Mail

May 16, 2026
pulisher
May 15, 2026

SMX increases authorized shares for incentive plan and grants restricted stock units - Investing.com

May 15, 2026
pulisher
May 07, 2026

XTL Biopharmaceuticals Wins Conditional Nasdaq Listing Reprieve Tied to Psyga Bio Deal - TipRanks

May 07, 2026
pulisher
Apr 30, 2026

XTL Biopharmaceuticals Delays 20-F Amid Subsidiary Liquidation - TipRanks

Apr 30, 2026
pulisher
Apr 29, 2026

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.57% - Investing.com

Apr 29, 2026
pulisher
Apr 29, 2026

XTL Biopharmaceuticals to Acquire PsygaBio in All-Stock Deal to Expand Psychedelic Drug Pipeline - TipRanks

Apr 29, 2026
pulisher
Apr 28, 2026

Double BottomStock ScreenerCharts - Finviz

Apr 28, 2026
pulisher
Apr 02, 2026

Top GainersStock ScreenerSnapshot - Finviz

Apr 02, 2026
pulisher
Apr 01, 2026

XTL Biopharmaceuticals Ltd ADR Each REPR 40 share price | XTLB - Hargreaves Lansdown

Apr 01, 2026
pulisher
Apr 01, 2026

Debt to assets ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – GETTEX:HHB0 - TradingView

Apr 01, 2026
pulisher
Apr 01, 2026

Total assets of XTL Biopharmaceuticals Ltd. Sponsored ADR – SWB:HHB0 - TradingView

Apr 01, 2026
pulisher
Apr 01, 2026

Return on invested capital % of XTL Biopharmaceuticals Ltd. Sponsored ADR – SWB:HHB0 - TradingView

Apr 01, 2026
pulisher
Apr 01, 2026

Free cash flow per share of XTL Biopharmaceuticals Ltd. Sponsored ADR – GETTEX:HHB0 - TradingView

Apr 01, 2026
pulisher
Apr 01, 2026

Tangible book value per share of XTL Biopharmaceuticals Ltd. Sponsored ADR – SWB:HHB0 - TradingView

Apr 01, 2026
pulisher
Apr 01, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Trade Ideas — SWB:HHB0 - TradingView

Apr 01, 2026
pulisher
Mar 27, 2026

Diluted earnings per share (diluted EPS) of XTL Biopharmaceuticals Ltd. Sponsored ADR – LS:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Cash Flow – LSX:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

Average basic shares outstanding of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

Total operating expenses of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView — Track All Markets

Mar 27, 2026
pulisher
Mar 27, 2026

EBITDA margin % of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

Diluted earnings per share (diluted EPS) of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

EBITDA margin % of XTL Biopharmaceuticals Ltd. Sponsored ADR – LS:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Statistics – LSX:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

Return on assets % of XTL Biopharmaceuticals Ltd. Sponsored ADR – LS:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

Basic earnings per share (basic EPS) of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView — Track All Markets

Mar 27, 2026
pulisher
Mar 27, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Statistics – LS:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

Basic earnings per share (basic EPS) of XTL Biopharmaceuticals Ltd. Sponsored ADR – LS:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 26, 2026

Price to cash flow ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – GETTEX:A41X7J - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Revenue per share of XTL Biopharmaceuticals Ltd. Sponsored ADR – GETTEX:A41X7J - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Statistics – GETTEX:A41X7J - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Balance Sheet – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Diluted earnings per share (diluted EPS) of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Total operating expenses of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Gross margin % of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Long term debt to total equity ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Price to sales ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Operating cash flow per share of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026

X T L Biopharmaceuticals Ltd Adr (XTLB) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$103.76
price up icon 0.86%
$126.29
price down icon 0.31%
$63.96
price up icon 0.13%
$266.11
price up icon 0.61%
ONC ONC
$358.26
price down icon 1.22%
$210.02
price down icon 0.40%
자본화:     |  볼륨(24시간):